Levamisole (150 mg per day) vs placebo
Decrease in duration of attacks · Participants with a previous or current history of recurrent aphthous stomatitis (RAS), diagnosed on history and clinical examination;…
Levamisole (150 mg per day) showed no clear difference in decrease in duration of attacks compared with placebo; GRADE not reported.
1 finding from 1 review
- Systemic interventions for recurrent aphthous stomatitis (mouth ulcers) 2012 · Cochrane All outcomesRR 4.29 [0.67, 27.24]1 studyGRADE not reported